“The number one reason patients stop taking Wegovy or Mounjaro is gastrointestinal distress,” says Curran. “The nausea, vomiting, diarrhea, and constipation can be really intense, especially if a dose ...

In the second part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains how dual-action metabolic therapies can address clinical or tolerability gaps observed in ...